Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 1/2019

01-07-2019 | Fertility | Gynecologic Oncology

Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases

Authors: Gokhan Boyraz, Yasin Durmus, Irfan Cicin, Oguzhan Kuru, Esra Bostanci, Gunsu Kimyon Comert, Hanifi Sahin, Hulya Ayik, Isin Ureyen, Alper Karalok, Mehmet Mutlu Meydanli, Mehmet Coskun Salman, Nejat Ozgul, Anil Onan, Tayup Simsek, Kunter Yuce, Taner Turan

Published in: Archives of Gynecology and Obstetrics | Issue 1/2019

Login to get access

Abstract

Purpose

To investigate the clinico-pathological prognostic factors and treatment outcomes in patients with ovarian yolk sac tumors (YST).

Methods

A multicenter, retrospective department database review was performed to identify patients with ovarian YST who underwent surgery between 2000 and 2017 at seven Gynecologic Oncology Centers in Turkey.

Results

The study group consisted of 99 consecutive patients with a mean age of 23.9 years. While 52 patients had early stage (stage I–II) disease, the remaining 47 patients had advanced stage (stage III–IV) disease. The uterus was preserved in 74 (74.8%) of the cases. The absence of gross residual disease following surgery was achieved in 76.8% of the cases. Of the 54 patients with lymph node dissection (LND), lymph node metastasis was detected in 10 (18.5%) patients. Of the 99 patients, only 3 patients did not receive adjuvant therapy, and most of the patients (91.9%) received BEP (bleomycin, etoposide, cisplatin) chemotherapy. Disease recurred in 21 (21.2%) patients. The 5-year disease-free survival (DFS) and overall survival (OS) in the entire cohort were 79.2% and 81.3%, respectively. In multivariate analysis, only residual disease following initial surgery was found to be significantly associated with DFS and OS in patients with ovarian YST (p = 0.026 and p = 0.001, respectively).

Conclusions

Our results demonstrate the significance of achieving no visible residual disease in patients with ovarian YST. Fertility-sparing approach for patients with no visible residual disease affected neither DFS nor OS. Although high lymphatic involvement rate was detected, the benefit of LND could not be demonstrated.
Literature
1.
2.
Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95(1):128–133PubMed
3.
Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107(5):1075–1085CrossRef
4.
Fujita M, Inoue M, Tanizawa O, Minagawa J, Yamada T, Tani T (1993) Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer 3(5):329–335CrossRefPubMed
5.
Kurman RJ, Norris HJ (1976) Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 38(6):2404–2419CrossRefPubMed
6.
de la Motte Rouge T, Pautier P, Genestie C, Rey A, Gouy S, Leary A et al (2016) Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors. Gynecol Oncol 142(3):452–457CrossRef
7.
Dällenbach P, Bonnefoi H, Pelte MF, Vlastos G (2006) Yolk sac tumours of the ovary: an update. Eur J Surg Oncol 32(10):1063–1075CrossRefPubMed
8.
Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH et al (2005) Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 96(3):784–791CrossRefPubMed
9.
Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I et al (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 24(30):4862–4866CrossRefPubMed
10.
Nawa A, Obata N, Kikkawa F, Kawai M, Nagasaka T, Goto S et al (2001) Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol 184(6):1182–1188CrossRefPubMed
11.
Kawai M, Kano T, Furuhashi Y, Mizuno K, Nakashima N, Hattori SE et al (1991) Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases. Cancer 67(1):184–192CrossRefPubMed
12.
Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R et al (2009) Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. Eur J Obstet Gynecol Reprod Biol 146(2):210–214CrossRefPubMed
13.
Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Holcomb K (2017) Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol Oncol 147(2):296–301CrossRefPubMed
14.
Mitchell PL, Al-Nasiri N, A’Hern R, Fisher C, Horwich A, Pinkerton CR (1999) Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer 85(10):2232–2244CrossRefPubMed
15.
Gershenson DM, Miller AM, Champion VL, Monahan PO, Zhao Q, Cella D et al (2007) Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol 25(19):2792–2797CrossRefPubMed
16.
Ayhan A, Taskiran C, Bozdag G, Altinbas S, Altinbas A, Yuce K et al (2005) Endodermal sinus tumor of the ovary: the Hacettepe University experience. Eur J Obstet Gynecol Reprod Biol 123(2):230–234CrossRefPubMed
17.
Mahdi H, Swensen RE, Hanna R, Kumar S, Ali-Fehmi R, Semaan A et al (2011) Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Br J Cancer 105(4):493–497CrossRefPubMedPubMedCentral
18.
de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F et al (2011) Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer 47(2):175–182CrossRef
19.
Wang X, Ma Z, Li Y (2016) Ovarian yolk sac tumor: the experience of a regional cancer center. Int J Gynecol Cancer 26(5):884–891CrossRefPubMed
20.
Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM et al (2016) Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14(9):1134–1163CrossRefPubMed
21.
22.
Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S et al (2011) Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Int J Gynecol Cancer 21(8):1414–1421CrossRefPubMed
23.
Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C (2012) Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii20–vii26PubMed
24.
Faure Conter C, Xia C, Gershenson D, Hurteau J, Covens A, Pashankar F et al (2018) Ovarian yolk sac tumors; does age matter? Int J Gynecol Cancer 28(1):77–84CrossRefPubMed
Metadata
Title
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases
Authors
Gokhan Boyraz
Yasin Durmus
Irfan Cicin
Oguzhan Kuru
Esra Bostanci
Gunsu Kimyon Comert
Hanifi Sahin
Hulya Ayik
Isin Ureyen
Alper Karalok
Mehmet Mutlu Meydanli
Mehmet Coskun Salman
Nejat Ozgul
Anil Onan
Tayup Simsek
Kunter Yuce
Taner Turan
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 1/2019
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-019-05160-6

Other articles of this Issue 1/2019

Archives of Gynecology and Obstetrics 1/2019 Go to the issue

General Gynecology

Maternal impacts and perinatal outcomes after three types of bariatric surgery at a single institution

Gynecologic Oncology

Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany

General Gynecology

Agreement assessment of key maternal and newborn data elements between birth registry and Clinical Administrative Hospital Databases in Ontario, Canada

Maternal-Fetal Medicine

Induction of labor versus expectant management for gestational diabetes mellitus at term

Gynecologic Oncology

Safety and effectiveness of robotic hysterectomy versus conventional laparoscopic hysterectomy in patients with cervical cancer in China

Gynecologic Endocrinology and Reproductive Medicine

The impact of sperm DNA fragmentation on ICSI outcome in cases of donated oocytes